CXCL5 has been found to be involved in tumor progression in numerous types of cancers and could serve as a potential serum biomarker in various malignancies, including breast, nasopharyngeal, gastric, colorectal, and biliary tract cancer [29]. The gene discussed is CXCL5; the disease is cancer.